Overview

Update
Total Equity Funding
$73.5M in 4 Rounds from 7 Investors
Most Recent Funding
$20M Debt Financing on September 17, 2014
Headquarters:
Redwood City, CA
Description:
Pulmonx provides minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.
Founders:
Categories:
Medical Device, Health Care, Biotechnology
Website:
http://www.pulmonx.com

Company Details

Update

Pulmonx Corporation, based in Redwood City, Calif., is focused on developing and marketing minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.

The company is currently engaged in the design, development and manufacture of products that will improve the effectiveness and benefits of endoscopic lung volume reduction (ELVR) for patients with severe emphysema. The company’s Zephyr® Endobronchial Valve (EBV) therapy* involves placing small one-way valves in the lung to prevent air from entering the most diseased regions while allowing fluids and trapped air to escape. The goal is to reduce the volume of the diseased portions of the lung, allowing increased ventilation to healthier areas of the lung.

The company has CE mark for the Zephyr Endobronchial Valves and has submitted a CE mark application for the Chartis System. The company has 510(k) marketing clearance for the Chartis System in the United States.

Funding Rounds (5) - $93.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2014$20M / Debt Financing1
Jan, 2012$10M / Private Equity5
Mar, 2010$32M / Series C7
Jan, 2010$11.5M / Venture0
May, 2007$20M / Series B4

Current Team (1)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • HQ

    700 Chesapeake Drive

    Redwood City, CA 94063

    USA

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos